Cody Lucas Bonte, ATC Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 W University Ave, Mitchell, SD 57301 Phone: 605-995-2600 |
Teah Serr, Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1421 S Rowley St, Mitchell, SD 57301 Phone: 605-830-2156 |
Alexis Schaffer, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2100 N Kimball St, Mitchell, SD 57301 Phone: 605-996-8712 |
News Archive
Bone marrow registries are usually noble efforts to find donors with the right genetic match to save the life of a terminally ill person, but one such program in New England is under investigation by attorneys general in two states (Greenberg, 12/17).
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
A new Cochrane review says that oxytocin, a medication often used to quicken slow-paced labor in its early stages, doesn't boost the prospects for normal births. Riskier births that required cesarean section or the use of forceps didn't become less common.
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
Patients with tumors that contain increased numbers of T lymphocytes generally survive longer than those with tumors without T-cell involvement, suggesting that T cells with potent antitumor function naturally exist in cancer and control tumor progression. With the exception of melanoma, it has been difficult to identify and isolate the tumor-reactive T cells from common cancers, however, the ability to do so could be used to fight a patient's own cancer.
› Verified 6 days ago